Stock listing
BIOPOR Stock Price, News, Filings & Events — Bioporto A/s
Selected listing: BIOPOR · OMXCOP · DKK · DK
This page tracks Bioporto A/s's BIOPOR:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOPOR:OMXCOP. BIOPOR:OMXCOP is the stock-level entry point for investors researching Bioporto A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioporto A/S is a public company based in Denmark, trading under the ticker BIOPOR. The company has a market capitalization of approximately 90.56 million USD. Bioporto focuses on developing and providing innovative diagnostic solutions.
- Ticker
- BIOPOR:OMXCOP
- Asset type
- Stock
- Market cap
- $90.1M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OMXCOP
- Currency
- DKK
Bioporto A/s BIOPOR:OMXCOP stock context
This page tracks Bioporto A/s's BIOPOR:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOPOR:OMXCOP. BIOPOR:OMXCOP is the stock-level entry point for investors researching Bioporto A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioporto A/S is a public company based in Denmark, trading under the ticker BIOPOR. The company has a market capitalization of approximately 90.56 million USD. Bioporto focuses on developing and providing innovative diagnostic solutions.
Latest news from Bioporto A/s
First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
September 16, 2026
BioPorto announces Interim Results for the Second Quarter and First half of 2026
August 20, 2026
BioPorto A/S to host an investor webcast on the results for the first half of 2026
August 12, 2026
BioPorto announces Interim Result for the First Quarter of 2026
May 21, 2026
Resolutions of the Annual General Meeting
April 24, 2026
Research Bioporto A/s
Bioporto A/s investor report
Review AI stock analysis and investor report context for BIOPOR:OMXCOP.
Bioporto A/s company profile
View the public company page for Bioporto A/s on 6ix.
Bioporto A/s news
Read company news and market updates connected to Bioporto A/s.
Bioporto A/s investor events
Find investor webinars, events, and replay context for Bioporto A/s.
Alternate listings
BIOPOC:AQUISEU
GB · DKK
Alternate listing for Bioporto A/s; the primary context on this page is BIOPOR:OMXCOP.
0JJM:LSE
GB · DKK
Alternate listing for Bioporto A/s; the primary context on this page is BIOPOR:OMXCOP.
BIOPOC:AQUISUK
GB · DKK
Alternate listing for Bioporto A/s; the primary context on this page is BIOPOR:OMXCOP.
THOXF:OTC
US · USD
Alternate listing for Bioporto A/s; the primary context on this page is BIOPOR:OMXCOP.
2P4:FWB
DE · EUR
Alternate listing for Bioporto A/s; the primary context on this page is BIOPOR:OMXCOP.
BIOPOC:TURQUOISE
GB · DKK
Alternate listing for Bioporto A/s; the primary context on this page is BIOPOR:OMXCOP.